Form 4 for IONS IONIS PHARMACEUTICALS INC
Accepted 2023-06-22 00:00:00 ET · period of report 2023-06-20 · accession 0000874015-23-000144 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-22 | 2023-06-20 | IONS | BERTHELSEN SPENCER R | Dir | M - OptEx | $28.47 | +11.2K | 140.1K | +9% | +$320.3K |
| D | 2023-06-22 | 2023-06-20 | IONS | BERTHELSEN SPENCER R | Dir | M - OptEx | $0.00 | -11.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-20 | M | A | 11,250 | $28.47 | 140,147 | D | — | — | (F1) Acquired as a result of exercising a stock option that was scheduled to expire on 6/30/2023 |
| 2 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-06-20 | M | D | 11,250 | $0.00 | 0 | D | $28.47 · 2014-07-01 to 2023-06-30 | 11,250 Common Stock |